Mankind Pharma Shareholding Pattern

As of Dec 2025, Mankind Pharma (MANKIND) promoter holding 72.66%, FII 11.34%, DII 13.25%, public 1.52%, total shareholders 177,539. For live price, key ratios and the full company profile, see MANKIND company profile.

Promoter Holding 72.66%
FII Holding 11.34%
DII Holding 13.25%
Public Holding 1.52%
Total Shareholders 177,539
As of Dec 2025

MANKIND Recent Shareholding Changes — Promoter, FII & DII

Mankind Pharma promoter, FII and DII holding change from Sept 2025 to Dec 2025 — promoter -0.01%, FII -1.5%, DII +1.33%. Examine MANKIND earnings for recent quarterly revenue, profit and EPS trends.

Promoter Holding Change
Sept 2025 to Dec 2025
-0.01%
FII Holding Change
Sept 2025 to Dec 2025
-1.5%
DII Holding Change
Sept 2025 to Dec 2025
+1.33%
Public Holding Change
Sept 2025 to Dec 2025
+0.16%

Mankind Pharma Quarterly Shareholding Trend — Promoter, FII, DII & Public

MANKIND promoter, FII, DII, public and government holding % by quarter — institutional ownership and promoter pledge trends. Review MANKIND P/E ratio to evaluate earnings-based valuation against sector peers.

Promoter
FII
DII
Public
Government

MANKIND Shareholding Pattern Data — Quarterly History

Mankind Pharma quarterly promoter, FII, DII, public holding % and total shareholders. Download as Excel or CSV.

Period Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Dec 2025 72.66% 11.34% 13.25% 0.00% 1.52% 1.23% 100.00% 177,539
Sept 2025 72.67% 12.84% 11.92% 0.00% 1.36% 1.21% 100.00% 170,347
Jun 2025 72.68% 13.07% 11.50% 0.00% 1.52% 1.23% 100.00% 179,549
Mar 2025 72.70% 12.92% 11.48% 0.00% 1.64% 1.26% 100.00% 180,597
Dec 2024 72.71% 13.34% 11.06% 0.00% 1.60% 1.30% 100.01% 172,431
Sept 2024 74.87% 12.37% 9.90% 0.00% 1.55% 1.31% 100.00% 163,854
Jun 2024 74.87% 11.58% 9.95% 0.00% 1.46% 2.15% 100.01% 153,450
Mar 2024 74.88% 9.87% 11.14% 0.00% 1.22% 2.89% 100.00% 135,116
Dec 2023 76.50% 0.00% 9.49% 0.00% 1.14% 12.87% 100.00% 127,449
Sept 2023 76.50% 0.00% 4.39% 0.00% 1.11% 18.00% 100.00% 134,731
Jun 2023 76.50% 0.00% 4.64% 0.00% 1.02% 17.83% 99.99% 131,918
May 2023 76.50% 0.00% 2.64% 0.00% 4.15% 16.71% 100.00% 402,322
Mar 2023 76.50% 0.00% 2.64% 0.00% 4.15% 16.71% 100.00% 402,322
Sept 2022 79.00% 0.00% 0.00% 0.00% 0.00% 21.00% 100.00% 17
Quarter Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Dec 2025 72.66% 11.34% 13.25% 0.00% 1.52% 1.23% 100.00% 177,539
Sept 2025 72.67% 12.84% 11.92% 0.00% 1.36% 1.21% 100.00% 170,347
Jun 2025 72.68% 13.07% 11.50% 0.00% 1.52% 1.23% 100.00% 179,549
Mar 2025 72.70% 12.92% 11.48% 0.00% 1.64% 1.26% 100.00% 180,597
Dec 2024 72.71% 13.34% 11.06% 0.00% 1.60% 1.30% 100.01% 172,431
Sept 2024 74.87% 12.37% 9.90% 0.00% 1.55% 1.31% 100.00% 163,854
Jun 2024 74.87% 11.58% 9.95% 0.00% 1.46% 2.15% 100.01% 153,450
Mar 2024 74.88% 9.87% 11.14% 0.00% 1.22% 2.89% 100.00% 135,116
Dec 2023 76.50% 0.00% 9.49% 0.00% 1.14% 12.87% 100.00% 127,449
Sept 2023 76.50% 0.00% 4.39% 0.00% 1.11% 18.00% 100.00% 134,731
Jun 2023 76.50% 0.00% 4.64% 0.00% 1.02% 17.83% 99.99% 131,918
May 2023 76.50% 0.00% 2.64% 0.00% 4.15% 16.71% 100.00% 402,322
Year Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Dec 2025 72.66% 11.34% 13.25% 0.00% 1.52% 1.23% 100.00% 177,539
Dec 2024 72.71% 13.34% 11.06% 0.00% 1.60% 1.30% 100.01% 172,431
Dec 2023 76.50% 0.00% 9.49% 0.00% 1.14% 12.87% 100.00% 127,449